Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $713.8400 (1.11%) ($713.8400 - $718.6100) on Fri. Oct. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.99% (three month average) | RSI | 43 | Latest Price | $713.8400(1.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.6% a day on average for past five trading days. | Weekly Trend | REGN declines -1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(35%) SPLV(32%) IWD(31%) SPY(31%) | Factors Impacting REGN price | REGN will decline at least -1.495% in a week (0% probabilities). TBT(-12%) UUP(-3%) VIXM(-2%) VCSH(-1%) VXX(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.495% (StdDev 2.99%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $721.26 | 5 Day Moving Average | $717.32(-0.49%) | 10 Day Moving Average | $726.74(-1.78%) | 20 Day Moving Average | $721.26(-1.03%) | To recent high | -5.2% | To recent low | 24.4% | Market Cap | $75.687b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |